Patrick Waters

Featured in: Favicon

nature.com Favicon

frontiersin.org Favicon

sagepub.com Favicon

springer.com Favicon

jamanetwork.com (+1) Favicon

edutopia.org Favicon

smartbrief.com Favicon

neurology.org (+1) Favicon

jimmunol.org + 3 more

Articles

The influence of MOGAD on diagnosis of multiple sclerosis using MRI - Nature Reviews Neurology

Sep 3, 2024 | nature.com | Ruth Geraldes |Georgina Arrambide |Alex Rovira |Hans Lassmann |Patrick Waters |Declan T. Chard | +6 more

AbstractMyelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an immune-mediated demyelinating disease that is challenging to differentiate from multiple sclerosis (MS), as the clinical phenotypes overlap, and people with MOGAD can fulfil the current MRI-based diagnostic criteria for MS. In addition, the MOG antibody assays that are an essential component of MOGAD diagnosis are not standardized.
Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: No

May 25, 2023 | journals.sagepub.com | Eoin P. Flanagan |Patrick Waters

Cite articleCite articleIf you have citation software installed, you can download article citation data to the citation manager of your choiceSelect your citation manager software:Information, rights and permissionsInformationPublished InArticle first published online: May 25, 2023Rights and permissions© The Author(s), 2023. Request permissions for this article.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →